Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

4.2K Views

09:20 min

October 18th, 2022

DOI :

10.3791/64389-v

October 18th, 2022


Transkrypcja

Przeglądaj więcej filmów

Adeno associated Virus AAV

Rozdziały w tym wideo

0:05

Introduction

1:16

Analysis of the AAV Viral Library (In Vitro) by NGS

3:42

Analysis of AAV Viral Library (In Vivo) by NGS

7:08

Results: Peptide Display AAV Capsid Engineering and Barcoded AAV Library Screening for Isolation of Next-Generation Gene Therapy Vectors

8:36

Conclusion

Powiązane Filmy

article

10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

9.4K Views

article

13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

8.7K Views

article

11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

7.2K Views

article

11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

10.2K Views

article

09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

2.2K Views

article

07:28

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation

2.6K Views

article

01:57

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

1.7K Views

article

01:52

Author Spotlight: Advancing Gene Therapy Research with High-Titer Adeno-Associated Virus Vector Production

904 Views

article

04:45

FPLC Purification and Characterization of Recombinant AAV

319 Views

article

04:00

Transfection and Harvesting Adeno-Associated Virus Vectors Using HEK293T Cells for Gene Therapy

238 Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone